Regional Analysis

Global Fluoroscopy Devices Market: Regional Insights

Based on geography, the global fluoroscopy devices market is segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.

Among regions, North America is expected to gain highest share in the market during the forecast period owing to the increasing burden of chronic diseases and growing geriatric population in the region. For instance, according to the Centers for Disease Control and Prevention (CDC), coronary artery disease (CAD) is the most common type of heart disease in the United States, killing 382,820 people in 2020. More than 20.1 million adults age 20 and older have CAD (about 7.2%). In 2020, about 2 in 10 deaths from CAD happen in adults less than 65 years old. In cardiac catheterization, fluoroscopy is used to evaluate the presence of arterial blockages.

Asia Pacific is also expected to witness significant growth in the global fluoroscopy devices market due to the high prevalence of cardiovascular diseases, growing geriatric population, and rising use of fluoroscopy devices in the region. For instance, according to the World Health Organization (WHO), around 3540,000 deaths occur in India due to cardiovascular disease (CVD), with it being more prevalent among the older population. Adults age 65 and older are more likely than younger people to suffer from cardiovascular disease. According to studies, India’s age-standardized CVD death rate is higher than the global average rate.

North America: U.S. and Canada
Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
Middle East: GCC Countries, Israel, and Rest of Middle East
Africa: South Africa, North Africa, and Central Africa